Denali Therapeutics financial statements

디날리 테라퓨틱스NASDAQ:DNLI · Nasdaq · Healthcare · sector #16
$19.28-3.16%
2026-10-06 close · prelim

Denali Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$487M.

Reported results

Denali Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q